Remove facilities containment-cleanrooms
article thumbnail

2nd Annual Aseptic Processing Conference

pharmaphorum

Cleanroom Managers. Implementation Strategy of Annex 1 in New or Existing Facilities. Led by: Richard Denk, Senior Consultant Aseptic Processing & Containment, Skan AG. Led by: Richard Denk, Senior Consultant Aseptic Processing & Containment, Skan AG. Leaders in Sterility Assurance. Regulatory Affairs Managers.

article thumbnail

Space to innovate: where are biotech’s top expansions?

Drug Discovery World

While there have been a significant number of new facilities built in the US, there have also been notable expansions for companies in India, the UK and Switzerland, among others.As Altasciences’ laboratory facilities in Columbia, MO (US), are undergoing a significant expansion, with completion expected in 2023.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Protecting the supply chain: Why biopharma needs integrated workflows

Pharmaceutical Technology

ILC Dover, specialists in the innovative design of biopharmaceutical manufacturing solutions, continuously monitors the market in order to provide in-demand equipment such as flexible containment solutions that reduce bottlenecks by providing closed, Grade-A, aseptic environments for fill and finish activities.

Packaging 130
article thumbnail

Pfizer to Slash COVID-19 Vaccine Manufacturing Time by Almost 50 Percent

XTalks

The RNA is transcribed from DNA in 40-liter vessels containing enzymes and chemicals over the course of three to four days. According to the report, “The air is filtered, the equipment constantly tested and all employees wear head-to-toe cleanroom coveralls to ensure nothing is introduced into the vaccine as it’s made.”.